|
C1ORF74 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14230000020288E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05130000038756E-07 |
| Normal-vs-Stage2 |
3.661700E-03 |
| Normal-vs-Stage3 |
2.539200E-01 |
| Normal-vs-Stage4 |
1.974450E-01 |
| Stage1-vs-Stage2 |
7.441600E-01 |
| Stage1-vs-Stage3 |
7.890500E-02 |
| Stage1-vs-Stage4 |
4.076000E-01 |
| Stage2-vs-Stage3 |
2.440200E-01 |
| Stage2-vs-Stage4 |
6.160800E-01 |
| Stage3-vs-Stage4 |
6.576000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48189999996207E-06 |
| Normal-vs-AfricanAmerican |
1.06109999675752E-08 |
| Normal-vs-Asian |
9.718400E-03 |
| Caucasian-vs-AfricanAmerican |
4.784200E-02 |
| Caucasian-vs-Asian |
7.660800E-01 |
| AfricanAmerican-vs-Asian |
7.481000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57240000020487E-07 |
| Normal-vs-Female |
5.188200E-04 |
| Male-vs-Female |
4.108600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.98169999999465E-05 |
| Normal-vs-Extreme_Weight |
3.19199999765374E-09 |
| Normal-vs-Obese |
4.75830000001842E-06 |
| Normal-vs-Extreme_Obese |
6.412300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.087000E-01 |
| Normal_Weight-vs-Obese |
9.628200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.860200E-01 |
| Extreme_Weight-vs-Obese |
1.741580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.727200E-01 |
| Obese-vs-Extreme_Obese |
8.556800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.293200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.53440000000482E-06 |
| Normal-vs-Age(61-80Yrs) |
6.11920000004318E-07 |
| Normal-vs-Age(81-100Yrs) |
1.57050000004766E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.996630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.589400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.072500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.735000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.439230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.062800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.78500000020443E-08 |
| Normal-VS-Type2 PRCC |
4.156500E-04 |
| Normal-VS-KIRP CIMP |
7.932400E-01 |
| Normal-VS-Unclassified PRCC |
8.208500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.375600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.157900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.048000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.581820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.806200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.532000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20660000000073E-05 |
| Normal-vs-N1 |
8.570600E-01 |
| Normal-vs-N2 |
1.503370E-03 |
| N0-vs-N1 |
2.635700E-02 |
| N0-vs-N2 |
4.716400E-01 |
| N1-vs-N2 |
1.581550E-01 |
|
|
